Discover 175 paid clinical trials in Burlington, Vermont. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 175
Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma
for
Glioblastoma, Gliosarcoma
Location: Burlington VT, Harrison NY, Montvale NJ, Commack NY,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 18+
Code: NCT06934889
Phase1, Recruiting
Exercise Capacity Before and After AF Ablation in Patients With HFpEF
for
Heart Failure With Preserved Ejection Fraction,
Location: Burlington VT
Sponsor: University of Vermont
Sex: All
Age: 18 - 70+
Code: NCT05376748
Recruiting
Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy
for
Peripartum Cardiomyopathy, Postpartum
Location: Burlington VT, Boston MA, Hartford CT, Providence RI,
Sponsor: Dennis M. McNamara, MD, MS
Sex: Female
Age: 18+
Code: NCT05180773
Recruiting
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
for
Advanced Melanoma
Location: Burlington VT, Lebanon NH, Providence RI, The Bronx NY,
Sponsor: Replimune, Inc.
Sex: All
Age: 12+
Code: NCT06264180
Phase3, Recruiting
Biomarkers of Independent Walking Post-Stroke
for
Stroke, Acute, Gait, Hemiplegic
Location: Burlington VT
Sponsor: University of Vermont
Sex: All
Age: 18+
Code: NCT05004389
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Contingency Management to Improve Medication for Opioid Use Disorder Continuation After the Emergency Department
for
Opioid Use Disorder
Location: Burlington VT
Sponsor: University of Vermont
Sex: All
Age: 18+
Code: NCT07129902
Recruiting
Fezolinetant for Treating Hot Flashes in Men With Prostate Cancer
for
Prostate CA, Androgen Deprivation Therapy
Location: Burlington VT
Sponsor: University of Vermont
Sex: Male
Age: 18+
Code: NCT06972875
Phase2, Recruiting
Nutritional Prehabilitation to Improve Cancer Outcomes (N-PICO)
for
Malnutrition, Cancer-related Malnutrition,
Location: Burlington VT
Sponsor: University of Vermont Medical Center
Sex: All
Age: 18+
Code: NCT07072377
Recruiting
Venous Thromboembolism Prevention in Outpatients With Glioma
for
Glioblastoma, Astrocytoma, Venous Thromboembolism
Location: Burlington VT
Sponsor: University of Vermont Medical Center
Sex: All
Age: 18+
Code: NCT05683808
Phase2, Recruiting
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
for
Clostridoides Difficile Associated Disease
Location: Burlington VT, East Syracuse NY, West Roxbury MA,
Sponsor: Pfizer
Sex: All
Age: 65+
Code: NCT07282665
Phase3, Recruiting
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Avoiding Radiation Therapy Due to Intracranial Response to Chemotherapy, Targeted Therapy and/or Immuno-ONcology Therapy for Brain Metastases: Pilot Pragmatic Trial
for
Brain Metastases, Adult,
Location: Burlington VT
Sponsor: University of Vermont Medical Center
Sex: All
Age: 18+
Code: NCT06974370
Phase2, Recruiting
MOHs Surgery and Short-Course Radiation Therapy With Structured Follow-Up for Head & Neck Squamous Cell Skin Cancer
Location: Burlington VT, Montreal, Ottawa, Boston MA, Hartford CT,
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Sex: All
Age: 18+
Code: NCT04031677
Phase3, Recruiting
Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC
for
Peritoneal Carcinomatosis
Location: Burlington VT, Lexington KY
Sponsor: Prakash Pandalai
Sex: All
Age: 18+
Code: NCT04779554
Phase2, Recruiting
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
for
Crohn's Disease
Location: Burlington VT, Hartford CT, New York NY, Toronto,
Sponsor: Eli Lilly and Company
Sex: All
Age: 2 - 17
Code: NCT05509777
Phase3, Recruiting
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer